We are live on ! Find out more
RA

Ramius Advisors Portfolio holdings

AUM $95.2M
1-Year Est. Return 7.33%
This Fund
S&P 500
This Quarter Est. Return
+32.12%
1 Year Est. Return
+7.33%
3 Year Est. Return
+186.73%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$233M
AUM Growth
-$193M
Cap. Flow
-$211M
Cap. Flow %
-90.87%
Top 10 Hldgs %
82.3%
Holding
91
New
44
Increased
8
Reduced
9
Closed
29

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$28M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$10.1M
3
TECD
Tech Data Corp
TECD
+$9.56M
4
CY
Cypress Semiconductor
CY
+$9.47M
5
BOLD
Audentes Therapeutics, Inc
BOLD
+$8.29M

Top Sells

Rank Stock Value
1
MLNX
Mellanox Technologies, Ltd.
MLNX
+$70.6M
2
CELG
Celgene Corp
CELG
+$68.9M
3
GHDX
Genomic Health, Inc.
GHDX
+$29.2M
4
ACIA
Acacia Communications Inc
ACIA
+$23.6M
5
AGN
Allergan plc
AGN
+$21.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.54%
2 Technology 17.91%
3 Consumer Discretionary 4.3%
4 Communication Services 3.04%
5 Financials 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PARA
51
PUT
DELISTED
Paramount Global Class B
PARA
$7K ﹤0.01%
97,900
+27,900
+40% +$1.08M
RTN
52
PUT
DELISTED
Raytheon Company
RTN
$7K ﹤0.01%
25,000
-5,000
-17% -$1.06M
ARQL
53
PUT
DELISTED
Arqule Inc
ARQL
$7K ﹤0.01%
+149,600
New +$1.73M
CNC icon
54
PUT
Centene
CNC
$31.3B
$6K ﹤0.01%
+85,000
New +$4.61M
DPLO
55
CALL
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$6K ﹤0.01%
+117,900
New +$554K
TEVA icon
56
CALL
Teva Pharmaceuticals
TEVA
$36B
$5K ﹤0.01%
+251,600
New +$2.25M
ABBV icon
57
PUT
AbbVie
ABBV
$458B
$4K ﹤0.01%
22,500
-77,500
-78% -$6.43M
WMGI
58
PUT
DELISTED
Wright Medical Group Inc
WMGI
$2K ﹤0.01%
+1,000
New +$26.2K
THOR
59
PUT
DELISTED
Synthorx, Inc. Common Stock
THOR
$2K ﹤0.01%
+34,900
New +$997K
DNR
60
CALL
DELISTED
Denbury Resources, Inc.
DNR
$1K ﹤0.01%
18,100
– –
AVX
61
PUT
DELISTED
AVX Corporation
AVX
$1K ﹤0.01%
+7,100
New +$122K
ACHN
62
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$1K ﹤0.01%
+16,000
New +$92.6K
AXTA icon
63
CALL
Axalta
AXTA
$7.1B
– –
-270,700
Closed -$263K
AXTA icon
64
Axalta
AXTA
$7.1B
– –
-268,319
Closed -$8.09M
BN icon
65
Brookfield
BN
$103B
– –
-177,856
Closed -$3.37M
CNC icon
66
CALL
Centene
CNC
$31.3B
– –
-230,900
Closed -$93K
CNC icon
67
Centene
CNC
$31.3B
– –
-338,085
Closed -$18.3M
EXAS
68
CALL
DELISTED
Exact Sciences
EXAS
– –
-287,300
Closed -$210K
EXAS
69
DELISTED
Exact Sciences
EXAS
– –
-41,258
Closed -$3.73M
GEN icon
70
CALL
Gen Digital
GEN
$15.7B
– –
-296,800
Closed -$382K
GEN icon
71
Gen Digital
GEN
$15.7B
– –
-273,330
Closed -$6.46M
PACB icon
72
Pacific Biosciences
PACB
$419M
– –
-167,354
Closed -$864K
PFE icon
73
Pfizer
PFE
$140B
– –
-107,081
Closed -$3.81M
RTX icon
74
PUT
RTX Corp
RTX
$287B
– –
-238,350
Closed -$114K
SMH icon
75
PUT
VanEck Semiconductor ETF
SMH
$68.5B
– –
-1,020,400
Closed -$99K
1 2
3
4

Similar funds

ACM
Acrisure Capital Management Austin, Texas $98.8M AUM
CWM
Catalyst Wealth Management Atlanta, Georgia $107M AUM
HLCM
Hickory Lane Capital Management New York $81.7M AUM 4.68% 1-Year Est. Return
ETM
Euclidean Technologies Management Seattle, Washington $109M AUM 7.18% 1-Year Est. Return
CFA
Compass Financial Advisors Fort Wayne, Indiana $78.9M AUM 0.9% 1-Year Est. Return
ACM
Ascendant Capital Management Los Angeles, California $75.7M AUM 12.68% 1-Year Est. Return
UPC
Utah Peaks Capital Park City, Utah $75.4M AUM
AMC
Asset Management Corp Northbrook, Illinois $128M AUM 6.72% 1-Year Est. Return

Ramius Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Ramius Advisors held 91 positions worth $233M, down 45% from $426M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Ramius Advisors withdrew a net $211M in Q4 2019, closing 29 positions and reducing 9 holdings. Its most notable exit was Celgene Corp, an estimated $68.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Ramius Advisors opened a new position in Medicines Co worth $35.7M.

  • Ramius Advisors's largest Q4 2019 buy was Medicines Co: 419,826 shares worth $35.7M.
  • Ramius Advisors added most to Wellcare Health Plans, Inc. in Q4 2019, an estimated $10.1M increase.
  • Ramius Advisors's biggest Q4 2019 reduction was Mellanox Technologies, Ltd., cutting an estimated $70.6M.
  • Ramius Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $68.9M.
  • Ramius Advisors's ten largest holdings make up 82% of its $233M portfolio in Q4 2019.
  • Ramius Advisors opened 44 new positions and closed 29 in Q4 2019.
  • Ramius Advisors's portfolio value fell 45% quarter-over-quarter to $233M.

Based on Ramius Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.